• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical characteristics, risk factors, and medical treatment of 561 patients with peripheral arterial disease followed in an academic vascular surgery clinic.

作者信息

Sukhija Rishi, Yalamanchili Kiran, Aronow Wilbert S, Kakar Priyanka, Babu Sateesh

机构信息

Department of Medicine, Cardiology Division, and the Division of Vascular Surgery, Westchester Medical Center/New York Medical College, Valhalla, New York 10595, USA.

出版信息

Cardiol Rev. 2005 Mar-Apr;13(2):108-10. doi: 10.1097/01.crd.0000128729.41155.a6.

DOI:10.1097/01.crd.0000128729.41155.a6
PMID:15705262
Abstract

The charts of all 561 patients (69% men and 31% women, mean age 71 +/- 10 years) with peripheral arterial disease (PAD) followed in an academic vascular surgery clinic were reviewed. Coexistent coronary artery disease (CAD) was present in 364 of 561 patients (65%). Of the 561 patients with PAD, 442 (79%) were current or exsmokers, 385 (69%) had hypertension, 225 (40%) had diabetes, 358 (64%) had a serum low-density lipoprotein (LDL) cholesterol > or =100 mg/dL, and 228 (41%) had a serum high-density lipoprotein cholesterol <40 mg/dL. Cilostazol or pentoxifylline was given to 301 of 301 patients (100%) with intermittent claudication. Aspirin or clopidogrel was given to 501 of 561 patients (89%) with PAD. Statins were given to 282 of 358 patients (79%) with PAD and an increased serum LDL cholesterol. If CAD was present, beta blockers were given to 301 of 364 patients (83%) and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers to 303 of 364 patients (83%).

摘要

相似文献

1
Clinical characteristics, risk factors, and medical treatment of 561 patients with peripheral arterial disease followed in an academic vascular surgery clinic.
Cardiol Rev. 2005 Mar-Apr;13(2):108-10. doi: 10.1097/01.crd.0000128729.41155.a6.
2
Optimal medical management of peripheral arterial disease.外周动脉疾病的优化医疗管理
Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. doi: 10.1177/1538574406291835.
3
Peripheral arterial disease in women.女性外周动脉疾病。
Maturitas. 2009 Dec 20;64(4):204-11. doi: 10.1016/j.maturitas.2009.10.001. Epub 2009 Oct 22.
4
Management of peripheral arterial disease.外周动脉疾病的管理
Cardiol Rev. 2005 Mar-Apr;13(2):61-8. doi: 10.1097/01.crd.0000126082.86717.12.
5
Office management of peripheral arterial disease.外周动脉疾病的门诊管理。
Am J Med. 2010 Sep;123(9):790-2. doi: 10.1016/j.amjmed.2010.03.017.
6
Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
Angiology. 2008 Oct-Nov;59(5):549-58. doi: 10.1177/0003319707309656. Epub 2008 Apr 2.
7
Long-term safety of cilostazol in patients with peripheral artery disease: the CASTLE study (Cilostazol: A Study in Long-term Effects).西洛他唑在周围动脉疾病患者中的长期安全性:CASTLE研究(西洛他唑:长期效应研究)
J Vasc Surg. 2008 Feb;47(2):330-336. doi: 10.1016/j.jvs.2007.10.009. Epub 2007 Dec 26.
8
In Germany diabetic patients with coronary artery disease are treated more intensively than diabetic patients with other manifestations of atherothrombosis--results from the REACH registry.在德国,患有冠状动脉疾病的糖尿病患者比患有动脉粥样硬化血栓形成其他表现的糖尿病患者接受更强化的治疗——来自REACH注册研究的结果。
Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):51-6. doi: 10.1055/s-0029-1225648. Epub 2009 Oct 15.
9
A new treatment for peripheral arterial disease.
Harv Heart Lett. 2001 Apr;11(8):1-3.
10
Atherosclerotic risk factor control in patients with peripheral arterial disease.外周动脉疾病患者的动脉粥样硬化危险因素控制
J Vasc Surg. 2005 May;41(5):816-22. doi: 10.1016/j.jvs.2005.01.047.

引用本文的文献

1
Limb salvage in women.女性肢体挽救
Methodist Debakey Cardiovasc J. 2013 Apr;9(2):84-9. doi: 10.14797/mdcj-9-2-84.
2
Peripheral arterial disease of the lower extremities.下肢外周动脉疾病。
Arch Med Sci. 2012 May 9;8(2):375-88. doi: 10.5114/aoms.2012.28568.
3
Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital.一家大型教学医院外周动脉疾病患者中风险降低疗法的使用未达最佳水平。
Ann Saudi Med. 2011 Jul-Aug;31(4):371-5. doi: 10.4103/0256-4947.83219.
4
Drug treatment of peripheral arterial disease in the elderly.老年人外周动脉疾病的药物治疗
Drugs Aging. 2006;23(1):1-12. doi: 10.2165/00002512-200623010-00001.
5
Evidence-based management of peripheral vascular disease.外周血管疾病的循证管理
Curr Atheroscler Rep. 2005 Sep;7(5):358-63. doi: 10.1007/s11883-005-0047-8.